Austria BASG

LIBTAYO 350 mg concentrate for solution for infusion – Recall

Original title: LIBTAYO 350 mg Konzentrat zur Herstellung einer InfusionslösungNeu

Recall of LIBTAYO 350 mg concentrate for infusion due to defective crimping.

Low obligation Product class Pharmaceuticals Austria Pharmacovigilance

LIBTAYO 350 mg Konzentrat zur Herstellung einer Infusionslösung Neu Rückruf | Humanarzneimittel | 24.07.2026 Rückruf aufgrund fehlerhafter Verbördelung

Dates and deadlines

Applies from

2026-07-24

Read the official source ↗

Published by Austria BASG. HealthSignal links to the original document; the summary above is extracted from the source text.